Clinical Trial Update: Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential drug-drug interaction between multiple doses of Epanova and a single dose of rosuvastatin (Crestor) in hypertriglyceridemia; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Epanova (icosapent ethyl)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertriglyceridemia | Phase 1 | Status: COMPLETED